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Plasma Membrane Targeting of
Endogenous NKCC2 in COS7 Cells
Bypasses Functional Golgi Cisternae
and Complex N-Glycosylation
Richa Singh, Shams Kursan, Mohamed Y. Almiahoub, Mohammed M. Almutairi,
Tomás Garzón-Muvdi, Francisco J. Alvarez-Leefmans and Mauricio Di Fulvio *
Department of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University, Dayton, OH, USA
Na+K+2Cl− co-transporters (NKCCs) effect the electroneutral movement of Na+-K+ and
2Cl− ions across the plasma membrane of vertebrate cells. There are two known NKCC
isoforms, NKCC1 (Slc12a2) and NKCC2 (Slc12a1). NKCC1 is a ubiquitously expressed
transporter involved in cell volume regulation, Cl− homeostasis and epithelial salt
secretion, whereas NKCC2 is abundantly expressed in kidney epithelial cells of the thick
ascending loop of Henle, where it plays key roles in NaCl reabsorption and electrolyte
homeostasis. Although NKCC1 and NKCC2 co-transport the same ions with identical
stoichiometry, NKCC1 actively co-transports water whereas NKCC2 does not. There is
growing evidence showing that NKCC2 is expressed outside the kidney, but its function in
extra-renal tissues remains unknown. The present study shows molecular and functional
evidence of endogenous NKCC2 expression in COS7 cells, a widely usedmammalian cell
model. Endogenous NKCC2 is primarily found in recycling endosomes, Golgi cisternae,
Golgi-derived vesicles, and to a lesser extent in the endoplasmic reticulum. Unlike
NKCC1, NKCC2 is minimally hybrid/complex N-glycosylated under basal conditions and
yet it is trafficked to the plasma membrane region of hyper-osmotically challenged cells
through mechanisms that require minimal complex N-glycosylation or functional Golgi
cisternae. Control COS7 cells exposed to slightly hyperosmotic (∼6.7%) solutions for
16 h were not shrunken, suggesting that either one or both NKCC1 and NKCC2 may
participate in cell volume recovery. However, NKCC2 targeted to the plasma membrane
region or transient over-expression of NKCC2 failed to rescue NKCC1 in COS7 cells
where NKCC1 had been silenced. Further, COS7 cells in which NKCC1, but not NKCC2,
was silenced exhibited reduced cell size compared to control cells. Altogether, these
results suggest that NKCC2 does not participate in cell volume recovery and therefore,
NKCC1 and NKCC2 are functionally different Na+K+2Cl− co-transporters.
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INTRODUCTION
The Na+K+2Cl− co-transporters (NKCCs) are membrane
proteins that carry out the electroneutral movement of Na+, K+,
and 2Cl− ions across the plasma membrane. These symporters
belong to the Slc12a family of solute carriers, which comprise
at least eight homologous genes: Slc12a1 (NKCC2), Slc12a2
(NKCC1), Slc12a3 (Na+-Cl− co-transporter, NCC), Slc12a4-
7 (K+-Cl− co-transporters, KCC1-4), and Slc12a9 (Hartmann
et al., 2014). NKCCs and NCCs actively accumulate Cl− in
cells, using the energy stored in the sum of the Na+, K+, and
Cl− chemical potential gradients, whereas KCCs mediate active
Cl− extrusion driven by the sum of the K+ and Cl− chemical
potential gradients. NKCCs and KCCs play important roles in
cell volume regulation, in the maintenance of the intracellular
chloride concentration ([Cl−]i) and in transepithelial solute and
water transport (Alvarez-Leefmans, 2012).
NKCC1 is a ubiquitously distributed protein (Gamba, 2005).
Molecular and/or functional expression of NKCC1 and its spliced
variants has been demonstrated in a variety of primary cells
types, including cell lines (Alshahrani et al., 2012; Mao et al.,
2012; Markadieu and Delpire, 2014; Singh et al., 2015). In
contrast, the main products of the Slc12a1 gene (NKCC2) i.e.,
NKCC2A, NKCC2B, and NKCC2F, have long been considered
to be exclusive to the apical membrane of the tubular cells of the
thick ascending loop of Henle (TALH). In this location, NKCC2
plays a key role in salt reabsorption and urine concentration
(Castrop and Schiessl, 2014). Mutations in the human SLC12A1
gene underlie neonatal Bartter’s syndrome type I, a disorder
characterized by severe dehydration, polyuria and electrolyte
imbalance (Simon et al., 1996). Although there is no doubt
that NKCC2 is abundantly expressed in the kidney and in
cell lines derived from the TALH (Eng et al., 2007) or the
macula densa (Fraser et al., 2007), there is growing evidence
showing relatively low levels of expression of extra-renal NKCC2.
For instance, NKCC2 expression has been reported in enteric
neurons (Xue et al., 2009), gastric, intestinal, endolymphatic sac,
and olfactory epithelia (Akiyama et al., 2007, 2010; Nickell et al.,
2007; Nishimura et al., 2009; Xue et al., 2009; Zhu et al., 2011;
Ji et al., 2012), starburst amacrine cells (Gavrikov et al., 2006),
chondrocytes (Bush et al., 2010), and endocrine/neuroendocrine
cells including insulin secreting β-cells of the pancreas (Corless
et al., 2006; Bensellam et al., 2009; Ghanaat-Pour and Sjöholm,
2009; Alshahrani et al., 2012; Alshahrani and Di Fulvio, 2012)
and vasopressinergic/oxytocinergic neurons of the supraoptic
and paraventricular nuclei (Hindmarch et al., 2006; Konopacka
et al., 2015).
Little is known about the functional role of extra-renal
NKCC2. In some cell types, NKCC2 is co-expressed withNKCC1,
but whether these proteins interact remains to be determined.
NKCC2 expression, plasma membrane localization and function
all increase in vasopressinergic and oxytocinergic neurons
expressing NKCC1 in rats subjected to chronic dehydration
(Hindmarch et al., 2006; Konopacka et al., 2015). These data
suggest that the Slc12a1 gene is responsive to osmotic stress.
In line with the latter, absence of NKCC1 in β-cells results
in permanent cell shrinkage and increased insulin secretion by
mechanisms related to increased NKCC2 expression (Alshahrani
andDi Fulvio, 2012; Alshahrani et al., 2015). NKCC1 andNKCC2
are not functionally equivalent; although both proteins transport
the same ions with the same stoichiometry (Gamba et al., 2009),
NKCC1 actively co-transports∼550 molecules of water per cycle
(Hamann et al., 2010), whereas NKCC2 is a “dry” co-transporter;
it does not transport water (Zeuthen and Macaulay, 2012).
Although the molecular determinants of these functional
differences between NKCC1 and NKCC2 are unknown, we
recently observed that knocking down NKCC1 in COS7 cells
resulted in increased NKCC2 expression that correlated with
NKCC2 immunolabeling near or at the plasma membrane
(Alshahrani et al., 2015). Since targeting of endogenous NKCC1
to the plasma membrane is independent of hybrid/complex N-
glycosylation (Singh et al., 2015) and genetic deletion of NKCC1
in some cells results in permanent cell shrinkage (Crum et al.,
2012), we hypothesized that NKCC2 expression increases in cells
subjected to sustained osmotic shrinkage by mechanisms that do
not require the classic secretory pathway. In the present report,
we confirm and extend previous results by demonstrating that:
(i) one splice variant of NKCC2, NKCC2A, is produced in COS7,
(ii) NKCC2 is natively expressed in COS7 cells at relatively low
levels, (iii) NKCC2 and NKCC1 co-localize to some but not all
cellular compartments, (iv) under basal conditions endogenous
NKCC2 localizes to the endoplasmic reticulum (ER), cis/medial
Golgi cisternae, pericentriolar/microtubule organizing center,
and endosomal compartments but not to lysosomes or the plasma
membrane region, (v) NKCC2 expression and plasma membrane
region localization increase in response to sustained exposure
to hyperosmotic solutions and (vi) complex N-glycosylation or
functional Golgi stacks are not required for NKCC2 targeting
to the plasma membrane region. Altogether, these data shed
new light on the cellular and molecular mechanisms involved
in membrane trafficking and osmotic sensitivity of extra-renal
NKCC2.
MATERIALS AND METHODS
Materials
Pfx DNA polymerase, RNase-OUT, SuperScript-III reverse
transcriptase, random hexamers, Lipofectamine2000 transfection
reagent, and baculovirus-mediated transduction systems for
Golgi detection (Bacman II) were from Invitrogen (Carlsbad,
CA); dNTPs, alkaline phosphatase and exonuclease I were
from Affimetrix/USB (Cleveland, OH); custom primers were
from Integrated DNA Technologies (Coralville, IA); the RNeasy
minikit was from Qiagen (Valencia, CA). General chemicals were
from Sigma (Saint Louis, MO). Tissue culture media, serum and
supplements were from Thermo-Fisher (Waltham, MA).
Antibodies
Monoclonal antibodies against tubulin (6G7) and lysosomal-
associated membrane protein-1 (LAMP, 2G9) were from
Developmental Studies Hybridoma Bank (DSHB, University
of Iowa). Rabbit anti-human β-actin antibodies were from
Cell Signaling Technology (Danvers, MA). Purified mouse
anti-Rab11 was from BD Transduction Labs (San Jose, CA).
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Anti-calreticulin (CRT) and chicken anti-human NKCC1
antibodies were from Thermo-Scientific (Rockford, IL).
Anti-NKCC2 antibodies were kindly provided by Dr. Pablo
Ortiz (Henry Ford Hospital, Detroit MI). Specific antibodies
against activated NKCC2 i.e., phospho-residue S126 were
kindly provided by Dr. Mark Knepper (Laboratory of Kidney
and Electrolyte Metabolism, NIH). Monoclonal antibodies
against α-mannosidase II (ManII) were a kind gift of
Dr. Brian Burke (Institute of Medical Biology, Singapore).
Rabbit polyclonal anti-FLAG antibodies were from GenScript
(Piscataway, NJ). The FITC-conjugatedMaackia amurensis lectin
(MAL) was from Vector Labs (Burlingame, CA). Conjugated
secondary antibodies for immunofluorescence microscopy or
Western blotting were from Jackson Immunoresearch (West
Grove, PA).
Cell Culture, Transfection, and Stable
Silencing
NKCC1-expressing COS7 cells (ATCC, Manassas, VA) were
grown and maintained in 6-well plates (BioLite, Thermo
Scientific), in DMEM supplemented with 10% FBS and
antibiotics. Cells were cultured in 5% CO2-95% air at 37
◦C.
The medium was changed every 2–3 days until confluence.
Plasmid transfection into COS7 cells was performed using
Lipofectamine2000 following the manufacturer’s instructions.
Full-length human NKCC2A (hNKCC2A) cDNA cloned
from human dorsal root ganglion cells (GenBank accession
number EF559316) was used to create expression plasmids.
The cloning plasmids harboring hNKCC2A cDNA wild
type (hNKCC2AWT) or mutants i.e., non-glycosylatable
(hNKCC2AN445/455Q) or lacking the last 181 residues
(hNKCC2A1C), were developed in the laboratory of one of
us (FJA-L). These cDNAs were introduced into pcDNA3.1
mammalian expression vectors and FLAG-tagged. Lentiviral
vectors expressing mCherry-tagged hNKCC2AWT were
from GeneCopoeia (Rockville, MD). To silence endogenous
NKCC1 or NKCC2 expression, COS7 cells were stably
transfected with human lentiviral constructs encoding
green fluorescent protein (GFP) and shRNAs against the
4th exon of hNKCC1, as previously described (Alshahrani
et al., 2015; Singh et al., 2015) or against the 20th exon of
hNKCC2. As control, we used constructs lacking shRNA
sequences.
RNA Extraction and RT-PCR
First-strand cDNA synthesis from total RNA and gene-specific
PCR was done as described in detail elsewhere (Alshahrani
et al., 2012; Grobe et al., 2015; Singh et al., 2015). Control RT-
PCR reactions were performed using glyceraldehyde phosphate
dehydrogenase (GAPDH, NM_002046) primers: GAPDH-555
sense: GTG AAG GTC GGA GTC AAC GGA TTT, GAPDH-
555 antisense: CAC AGT CTT CTG GGT GGC AGT GAT. The
PCR primers used to amplify NKCC2 as overlapping fragments
of the whole open reading frame (ORF, nucleotide position: 1
to 3300) and partial un-translated sequences (5′- and 3′-UTRs,
positions–218 to 1 and 3301 to 3819, respectively) of NKCC2A
are shown in Supplementary Table 1. Primer design and in silico
analysis of sequences obtained were performed using Geneious
R9 (Biomatters Ltd., Auckland, New Zealand).
Western Blotting
Fifty to one hundred micrograms of total protein from COS7
cells were subjected to SDS-PAGE (pre-casted gels 4–20%
Pierce, Thermo Scientific, Rockford, IL), transferred to PDVF
membranes and blotted as described in detail elsewhere (Singh
et al., 2015). β-actin expression was used as internal loading
control. Western blots were developed by the ECL method
(SupersignalWest Pico, Pierce) using HRP-conjugated secondary
antibodies.
Immunofluorescence and Cell Cross
Sectional Area Measurements
COS7 cells were grown on glass coverslips placed on 6-well
plates and immunolabeled as previously described (Singh et al.,
2015). Immunolabeled cells attached to coverslips were mounted
using Vectashield containing 4′-6-diamidino-2-phenylindole
(DAPI, Vector Labs, Burlingame, CA) to counterstain the cell
nuclei. Slides were visualized in an Olympus Epi Fluorescence
microscope with RT color camera using 60x or 100x oil objectives
and appropriate fluorescence filters or an FV1000 Confocal
Microscope (Olympus, PA, USA). Non-confocal micrographs
were obtained using a digital camera (Diagnostics Instrument
Spot 6 digital). Cell edges were visualized on digital pictures
(RGB, 600dpi) using ImageJ software (NIH) and applying the
Canny-Deriche filtering plugin. Co-localization was estimated
by applying the co-localization colormap plugin of ImageJ to 8-
bit transformed images. Cell surface area (squared pixels) was
obtained using the free-hand selection tool to draw cell edges
and transformed to µm2 based on a microscope scale set at 600x
magnification (1350 pixels= 125 µm).
Bumetanide-Sensitive Cl− Uptake
The total intracellular content of Cl− was determined in non-
confluent COS7 cells grown in 12 well-plastic plates using
calibrated ion-selective electrodes (Orion-Thermo Scientific,
Rockford, IL), as described previously (Singh et al., 2015).
Briefly, cells were washed and depleted of endogenous Cl−
at room temperature in isotonic (ISO, ∼300 mOsm/Kg H2O)
media of the following composition (in mM): 0.83 Na2HPO4,
1 Mg2SO4, 20 HEPES, 10 mannose, 130, 5 and 2 Na
+, K+,
and Ca2+ gluconate salts, respectively. After incubation for 1 h
in this Cl−-free media, cells were exposed to control medium
containing physiological Cl− concentrations i.e., gluconate salts
were replaced with equimolar amounts of NaCl, KCl, and CaCl2,
and cells were allowed to accumulate Cl− ions for 5 min. The
uptake process was terminated placing cells on ice and washing
them in ice-cold Cl−-free ISO solutions. The total cellular Cl−
content was determined potentiometrically in neutralized 0.25
N NaOH cellular extracts, calculated and expressed as nmol of
Cl− perµg of total protein. The bumetanide (BTD)-sensitive Cl−
uptake was defined as the difference between Cl− accumulated
under control conditions to that obtained in the presence of
10µM BTD.
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Statistical Analysis
Analysis of multiple group differences was performed by one-way
analysis of variance (ANOVA) followed by Student-Newman-
Keuls’ test. P-values lower than 0.05 were considered of statistical
significance.
RESULTS
COS7 Cells Express a Single Splice Variant
of NKCC2
Using immunolabeling methods it was shown that COS7 express
low but significant levels of NKCC2 (Alshahrani et al., 2015).
However, the splice variant/s of NKCC2 were not identified.
In the present paper we used RT-PCR and specific primer
sets (Supplementary Table 1) designed to amplify known splice
variants of the co-transporter i.e., NKCC2A, NKCC2B, and
NKCC2F. Bands of predicted sizes were amplified from total
RNA obtained from COS7 cells demonstrating expression of
NKCC2 transcripts. Figure 1E shows the partial nucleotide
sequence of the NKCC2-612 fragment predicted to co-amplify
NKCC2A, B and F transcripts (Figure 1B). In silico analysis of
the entire sequence of this RT-PCR fragment demonstrated 98%
identity to hNKCC2A or chimpanzee’s NKCC2A (ptNKCC2A).
Thus, the NKCC2 variant endogenously expressed in COS7
cells is likely NKCC2A. Exon B or F sequences were not
detected in this 612 bp fragment suggesting that neither
NKCC2B nor NKCC2F are expressed in COS7 cells. Further,
the nucleotide sequences of RT-PCR fragments of 540 bp
confirmed the presence of NKCC2A (not shown). To provide
additional evidence of NKCC2A expression in COS7 cells, the
complete open-reading frame (ORF) plus 3’/5’-UTR sequences
corresponding to NKCC2A mRNAs were PCR-amplified in
overlapping fragments and fully sequenced in both directions.
The predicted translation product and topology of the nucleotide
sequence of NKCC2A expressed in COS7 (GenBank accession
number: JQ708180) is shown in Supplementary Figure 1. In silico
analysis and comparison of NKCC2 cDNAs cloned from COS7
with the human NKCC2A sequence of reference (NM_000338)
and with hNKCC2A cloned from dorsal root ganglion cells
(EF559316) or kidney (U58130) reveals >98% pairwise identity
between cDNA and ORF sequences (not shown).
To extend these results at the protein level, NKCC2 was
immuno-detected in blots of protein extracts from COS7
cells and kidney tissues from WT mouse and mouse lacking
FIGURE 1 | Endogenous NKCC2A expression in COS7 cells. (A) Representation of chimpanzee NKCC2A mRNA sequence of reference (ptNKCC2A, RefSeq
NM_001110839), inferred from genomic sequences. The 28 coding exons are represented as gray filled arrows, numbered relative to the first coding exon (exon 1).
The protein predicted in silico has 1099 amino acids and it is represented as a black-filled arrow on top of this panel. The predicted RT-PCR fragments amplified using
the NKCC2 primer sets are represented as white arrows, and are labeled as follows: NKCC2A-540, NKCC2-612, NKCC2-527, and NKCC2-870. (B) Representation
of mouse NKCC2 splicing variants mNKCC2A, mNKCC2B, and mNKCC2F showing the encompassing primer set NKCC2-612, predicted to co-amplify NKCC2A, B
and F. (C) Representative RT-PCR experiment performed using NKCC2 primer sets indicated in B. Shown is a 2% agarose gel showing bands of predicted size for
NKCC2 i.e., 540, 612, 527, and 870 bps. RT-PCR reactions included amplification of GAPDH (555bp). Negative controls were performed using H2O instead of RNA
and GAPDH-555 primer set. (D) Immunoblot of COS7 lysates (left) showing NKCC2 protein expression as bands of ∼120kDa, ∼135kDa, and ∼165kDa. As positive
control for NKCC2 expression, whole mouse kidney lysates obtained from WT and NKCC1KO mice (right panel) were run in parallel. (E) Partial nucleotide sequence of
the RT-PCR amplicon obtained with NKCC2-612 primer set. The band of 612bp (asterisk) was sequenced in both directions. The sequence chromatogram shown is
representative of 6 different amplification reactions and corresponds to the region encompassing exon A of COS7 NKCC2A mRNA.
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NKCC1 (NKCC1WT and NKCC1KO, respectively) as controls
for potential cross-contamination with NKCC1. As shown in
Figure 1D, endogenous NKCC2 is detected mainly as a band
of ∼120 kDa corresponding to core/high mannose version
of the transporter. Additional bands of ∼140–170 kDa were
also detected. The latter bands correspond to hybrid/complex
N-glycosylated NKCC2. Immunoblots from kidney proteins
confirmed the well-known band pattern of NKCC2 i.e., two
bands, one of ∼120 kDa and the other of ∼165 kDa (Paredes
et al., 2006). Taken together, these results confirm and extend
previous data (Alshahrani et al., 2015) and suggest that the
NKCC2 expressed in COS7 cells is NKCC2A and that most of
it corresponds to the core/high mannose N-glycan version of the
transporter.
Endogenous NKCC2 Is Not Localized to
the Plasma Membrane Region of COS7
Cells
NKCC2 is found widespread in intracellular compartments of
non-epithelial cells including hypothalamic neurons (Konopacka
et al., 2015), insulin-secreting β-cells (Alshahrani et al.,
2012; Alshahrani and Di Fulvio, 2012), or COS7 cells in
culture (Alshahrani et al., 2015). To identify the intracellular
compartments in which NKCC2 is expressed in COS7, triple
immunolabeling of NKCC2, integrin β2 (Iβ2), and NKCC1 was
performed. Iβ2 is a putative plasma membrane marker whereas
NKCC1 is not only expressed in the plasma membrane but
also in the endoplasmic reticulum (ER), Golgi cisternae and
endosomes of COS7 cells (Singh et al., 2015). As expected,
both Iβ2-IR (Figure 2A) and NKCC1-IR (Figure 2B) were found
in or in close proximity to the plasma membrane as well as
in perinuclear compartments. As shown in Figure 2D, Iβ2-
and NKCC1-IR extensively overlapped. However, NKCC2-IR
(Figure 2C) does not exhibit an expression pattern consistent
with plasmamembrane localization in these cells. In fact, NKCC2
is mainly found in Iβ2- or NKCC1-negative compartments
(Figure 2F) and it is barely detected in the plasma membrane
region of COS7 cells. To obtain further evidence for the lack
of endogenous NKCC2 expression in the plasma membrane,
NKCC2 was co-immunolabeled with fluorescein-conjugated
M. amurensis lectin (MAL), a carbohydrate binding protein
used to label plasmamembrane-associated carbohydratemoieties
(Wu et al., 2006). The results show that NKCC2 and MAL
do not co-localize further suggesting that plasma membrane
localization of the co-transporter is minimal or undetectable
under basal control conditions in COS7 cells (Figures 2G–L).
To determine if this immunolocalization pattern correlates with
the relatively low expression levels of endogenous NKCC2, COS7
cells grown in glass coverslips were transfected with a lentiviral
vector encoding mCherry-tagged hNKCC2AWT (∼4 µg). Cells
exhibiting different levels of expression of mCherry-tagged
hNKCC2AWT were imaged using direct immunofluorescence
microscopy (Figures 2J–L) and digital images were filtered to
detect cells’ edges. Figures 2M–R show that over-expressed
hNKCC2AWT localizing toward the cell’s edges increases with
the expression levels of hNKCC2AWT. This observation suggests
that plasma membrane localization of NKCC2 is a function of its
expression levels.
Endogenous NKCC2 Localizes in
Intracellular Vesicular Compartments
To identify the intracellular compartments where NKCC2 is
localized, double immunolabeling experiments were performed
using Rab11, a marker of perinuclear recycling endosomes
and Golgi-derived vesicles (Ullrich et al., 1996). As shown in
Figures 3A–C, endogenous NKCC2 extensively co-localize in
Rab11-positive vesicles. However, NKCC2-IR was also observed
in intracellular compartments other than Rab11-positive
vesicles. These compartments appeared as discrete structures
near one of the nuclear poles and in small cytoplasmic vesicles
(Figure 3A, white arrows). These compartments may represent
the microtubule organizing center (MTOC)/pericentriolar
compartment (PC), Golgi stacks or lysosomes (Lippincott-
Schwartz, 1998). To define Golgi localization, endogenous
NKCC2 was immunolabeled in COS7 cells either transduced
with GFP-tagged N-acetyl-galactosaminyl transferase-2 (GFP-
NGAT), a cis-Golgi resident enzyme, or co-immunolabeled
with α-mannosidase II (ManII), a trans-Golgi resident enzyme
(Burke et al., 1982). Figures 3D–I show NKCC2A co-localization
with GFP-NGAT and ManII, demonstrating that the co-
transporter locates in Golgi cisternae. Furthermore, as shown in
Figures 3J–L, endogenous NKCC2 partially co-localized with
tubulin [TUB, microtubule marker (Desai and Mitchison, 1997)]
at one of the poles of the cell but not in radiating tubulin-positive
structures or in compartments positive for the lysosomal marker
LAMP (Figures 3M–O). The extent of NKCC2 co-localization
with Rab11, GFP-NGAT, ManII, TUB, or LAMP is shown in
their respective heat-maps (Figure 3P). Taken together, these
results strongly suggest that endogenous NKCC2 in COS7
cells is mainly expressed as an intracellular protein localized
in endosomal vesicular compartments, Golgi cisternae and in
structures resembling the MTOC/PC.
Endogenous NKCC2 Trafficking Does Not
Require Functional Golgi Compartments in
COS7 Cells
Since most of the NKCC2 in COS7 cells appears as a core/high
mannose N-glycosylated protein i.e., ∼120 kDa (Figure 1D),
the transporter is expected to be localized in ER, where all
proteins are synthesized. This hypothesis was tested using double
immunolabeling of NKCC2 and calreticulin (CRT), an ER-
resident chaperone. As shown in Figure 4, NKCC2 and CRT co-
localize in COS7 cells cultured under control basal conditions
(Figures 4A–C). In fact, when protein synthesis was inhibited
by exposing the cells for 2 h to cycloheximide the expression
of NKCC2 in the ER was significantly reduced (Figures 4D–F).
This can be more clearly visualized in co-localization heat-maps
(Figures 4D–H).
To determine the impact of the first step in N-glycan
biosynthesis on NKCC2 stability and intracellular trafficking,
COS7 cells were treated for 16 h with vehicle (0.2% DMSO) or
with vehicle plus tunicamycin (TUN, 2µg/ml), a blocker of the
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FIGURE 2 | Endogenous NKCC2 does not localize to the plasma membrane region of COS7 cells under basal normotonic conditions. (A–C) Confocal
immunofluorescence microscopy images of sub-confluent COS7 cells immunolabeled with primary antibodies directed against integrin β2 (Iβ2, A), NKCC1 (B), and
NKCC2 (C). The secondary antibodies were conjugated to AF488 (green), Cy3 (red), and DyLight405 (blue), respectively. (D) Overlays of (A; Iβ2) and (B; NKCC1). (E)
Overlays of (A; Iβ2) and (C). (F) Overlays of (A; Iβ2), (B; NKCC1), and (C; (NKCC2). (G–I) Immunofluorescence microscopy images of fixed and permeabilized COS7
cells labeled with FITC-conjugated Maackia Amurensis lectin (MAL, G) to visualize cell membranes (arrowheads). Cells were also probed against NKCC2 coupled to
(Continued)
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FIGURE 2 | Continued
Cy3-conjugated secondary antibodies (H) and the images superimposed (I). In (G–I), cell nuclei were counterstained using DAPI. (J–L) Visualization of cell edges of
images (G–I) by using ImageJ and applying the Canny-Deriche filtering plugin. Note the lack of NKCC2-IR in the overlay image shown in (L). (M–O) Direct
immunofluorescence microscopy of COS7 cells growing in glass coverslips and over-expressing different levels of the lentiviral vector mCherry-NKCC2AWT. (P,R)
Visualization of the edges of the transfected cells shown in (M–O) by applying the Canny-Deriche filtering plugin of ImageJ. All images were taken at 600x
magnification. Bar represents 10µm.
first step of N-glycan biosynthesis. As shown in Figures 5A–C,
NKCC2 and CRT co-localized in control DMSO-treated COS7
cells to an extent similar to that shown in Figure 4, indicating that
DMSO does not visibly impact endogenous NKCC2 immuno-
localization. However, in contrast with what has been shown for
NKCC1 in COS7 cells (Singh et al., 2015), treatment with TUN
did not result in evident NKCC2 degradation or retention in the
ER. Moreover, NKCC2 appeared completely deglycosylated in
immunoblots from proteins extracted from TUN-treated COS7
cells (Figure 6A). Immunofluorescence microscopy revealed that
in cells treated with TUN, NKCC2 appeared as vesicle-like
punctate structures throughout the cytoplasm (Figures 6B,C),
and surprisingly, it was also clearly localized in plasmamembrane
region (Figures 6B–D). These results indicate that endogenous
NKCC2 in COS7 cells targeting to the plasma membrane is
independent of N-glycans biosynthesis.
To determine whether the co-transporter is able to bypass
the classic ER-Golgi secretory route, NKCC2 immunolocalization
was studied in COS7 cells treated with brefeldin-A (BFA,
2 µg/ml, 16 h), an antibiotic that inhibits retrograde cargo
transport from Golgi to ER and anterograde delivery from post-
Golgi compartments (Grieve and Rabouille, 2011). As shown in
Figures 6E–G, in COS7 cells treated with BFA NKCC2 appears
localized at or near the plasma membrane. These results indicate
that NKCC2 may traffic directly from the ER to the plasma
membrane.
NKCC2 Expression Pattern Changes upon
Sustained Osmotic Stress
Since NKCC2 reaching of the plasma membrane region of COS7
cells is independent of functional Golgi and chronic osmotic
stress increase NKCC2 expression in COS7 cells (Alshahrani
et al., 2015), here we explored whether NKCC2 lacking N-
glycans traffics to the plasma membrane of osmotically stressed
cells. To this end, COS7 were transiently transfected with ∼2
µg of FLAG-tagged hNKCC2AWT, hNKCC2A1C [a truncated
mutant lacking the last 181 C-terminal residues, known to
be retained in the ER when over-expressed in cells (Zaarour
et al., 2009)] or hNKCC2AN446/456Q [a non-glycosylatable
mutant unable to reach the plasma membrane when over-
expressed in mammalian cells (Benziane et al., 2007)]. Forty-
eight hours post-transfection, cells were incubated in isotonic
serum-free medium (∼300 mOsm/Kg H2O) alone, or for 16 h
in slightly hyperosmotic (∼6.7%) serum-free medium prepared
by adding 19.5 mM mannitol giving a final osmolality of
∼320 mOsm/Kg H2O. Cells were then fixed and processed for
immunofluorescence microscopy using anti-FLAG antibodies.
As shown in Figure 7A, transiently over-expressed hNKCC2AWT
localizes in intracellular compartments rather than in or near
the plasma membrane, whereas hNKCC2A1C (Figure 7B) or
hNKCC2AN446/456Q (Figure 7C) were retained in intracellular
structures, as previously shown (Benziane et al., 2007; Zaarour
et al., 2009). Interestingly, long-lasting (16 h) exposure of the
transfected cells to slightly hyperosmotic medium resulted in
a redistribution of hNKCC2AWT toward the edges of the
cells retargeting intracellularly retained NKCC2A mutants.
Altogether, these results suggest that NKCC2A traffics to the
plasma membrane in response to long-lasting incubation in
slightly hyperosmotic media and that this phenomenon does not
require functional Golgi cisternae.
NKCC2 Expression in Response to
Sustained Hyperosmotic Stress Does Not
Recover Cell Size
Molecular elimination or pharmacological down-regulation of
NKCC1 in COS7 or insulin-secreting β-cells results in increased
NKCC2 expression (Alshahrani et al., 2015). Interestingly, these
cells are permanently smaller than WT cells, suggesting that
NKCC2 expression does not result in cell size recovery. To gain
insights into the potential functional role of NKCC2 in NKCC1-
silenced COS7 cells [COS7shNKCC1, (Singh et al., 2015)], we
explored the relation between NKCC2 up-regulation and cell size
as a function of shRNA-mediated NKCC1 silencing. As shown in
Figure 8A, gradual silencing of NKCC1 in COS7 cells results in
parallel up-regulation of NKCC2 expression, whereas the mean
cell area of COS7shNKCC1 cells is significantly reduced when
compared to that of COS7shControl. These results can be further
observed in the micrographs shown in Figure 8C, where GFP-
expressing COS7shNKCC1, but not COS7shNKCC2 cells, exhibits
reduced cell size when compared to that of COS7shControl cells.
To determine if the decrease in cell size of COS7shNKCC1
cells relates to changes in intracellular ionic composition, the
basal cellular Cl− content was estimated. Figure 8D shows
that BTD decreased total Cl− content of COS7shControl but
not in COS7shNKCC1 cells, suggesting that NKCC2 may not
participate in the maintenance of basal cellular Cl− content
in a BTD-sensitive manner, in spite of the fact in these cells
NKCC2 was up-regulated (Figure 8A) and localized in the
plasma membrane region (Figure 8E) or upon long-lasting
pharmacological inhibition of NKCC1 (Alshahrani et al., 2015).
Together, these results suggest that silencing of NKCC1, but not
NKCC2, impacts cell size and total Cl− content. This is consistent
with the notion that NKCC2 and NKCC1 are not functionally
equivalent, in terms of cell water volume control (Hamann et al.,
2010; Zeuthen andMacaulay, 2012) and BTD sensitivity (Gamba,
2005). To test this hypothesis, shrunken COS7shNKCC1 cells were
transiently transfected with mCherry-hNKCC2AWT and cross
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FIGURE 3 | Endogenous NKCC2 localizes to recycling endosomes, Golgi cisternae, and tubulin-positive structures. Immunofluorescence microscopy
images of sub-confluent COS7 cells grown in glass coverslips were permeabilized and immunolabeled with markers of intracellular organelles. (A–C) COS7 cells
labeled with primary antibodies against NKCC2 (A) and Rab11, a marker of the recycling endosomal compartment (B). Co-localization of NKCC2 and Rab11 is
shown in the merged image (C), where the withe arrowheads indicate NKCC2 localization in structures lying at one of the poles of the cell or in vesicles. (D–F) COS7
cells transduced with GFP-NGAT constructs to visualize the Golgi compartments (E) and then permeabilized and immunolabeled against NKCC2 (D, F). (G–I) COS7
cells immunolabeled against NKCC2 (G) and α-mannosidase II, a marker of trans-Golgi cisternae (ManII, H). Localization of NKCC2 to Golgi compartments is shown
in the respective merged images (F and I). (J–L) COS7 cells immunolabeled against NKCC2 (J) and tubulin (K) showing localization of the transporter to structures
resembling the MTOC/pericentriolar compartment (L). (M–O) Expression of NKCC2 (M) and the lysosomal marker LAMP (N) were detected but not co-localized (O).
The cell nuclei were counterstained with DAPI in all micrographs. All micrographs were taken at 600x. Bar represents 10 µm. (P) Co-localization heat-map of the cells
framed with a white rectangle in (C, F, I, L, and O), computed by using the NIH ImageJ co-localization plugin.
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FIGURE 4 | NKCC2 localizes to the ER of COS7 cells. (A–D) COS7 cells immunolabeled against NKCC2 (A) or calreticulin (CRT, B), a calcium-binding protein
that resides in the ER. Secondary antibodies were: Cy3 (NKCC2, red) and AF488 (CRT, green). The co-localization of NKCC2 and CRT is shown in C, a merged image
of (A,B), and in the heat-map shown in (D), which corresponds to the cell labeled with a yellow arrow. (E–H) Images of COS7 cells grown in the presence of
cycloheximide (CHX, 1 µg/ml, 2 h) to acutely inhibit ongoing protein synthesis in the ER. NKCC2 (E) and CRT (F) were detected by using the relevant primary
antibodies and secondary antibodies labeled with Cy3 (red) and AF488 (green). Merged images (E,F) show degree of co-localization on heat-maps (G–H).
Frontiers in Cell and Developmental Biology | www.frontiersin.org 9 January 2017 | Volume 4 | Article 150
Singh et al. Endogenous NKCC2A and Regulation of Cell Size
FIGURE 5 | Inhibition of N-glycosylation results in redistribution of endogenous NKCC2 in COS7 cells. Immunofluorescence microscopy images of COS7
cells grown under control conditions (DMSO 0.2% used as vehicle, 16 h, A–D) or treated with 2µg/ml tunicamycin (TUN plus vehicle, 16 h E–H). NKCC2 and CRT
co-localization is shown in merged images (C,G), which were used to compute their respective co-localization heat maps (D,H). Bars represent 10µm.
sectional cell area wasmeasured 36 h post-transfection. As shown
in Figures 9A–D, over-expression of mCherry-hNKCC2AWT
did not significantly change COS7shNKCC1 cell size suggesting
that NKCC2A does not restore cell volume in shrunken cells
lacking NKCC1. To determine if these effects are related to
the phosphorylation state of NKCC2, cells grown in coverslips
under isotonic conditions were immunolabeled against activating
phospho-residue S126 in NKCC2. The results show that NKCC2
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FIGURE 6 | The first step of N-glycan biosynthesis impairs
N-glycosylation of NKCC2 but not its expression or trafficking. (A)
Representative immunoblots showing NKCC2 expression in protein extracts
from COS7 cells that were grown under control conditions (0.2% DMSO) or
treated with TUN (2µg/ml, 16 h). Note the cotransporter’s bands of ∼120 kDa,
∼135 kDa, and ∼160 kDa in control immunoblots. In contrast, protein
extracted from cells treated with TUN only showed a band at ∼120 kDa.
β-actin was used as loading control. (B–D) Confocal images of COS7 cells
grown in control conditions (DMSO 0.2% used as vehicle) immunolabeled
against NKCC2 and visualized with Cy3-conjugated secondary antibodies
(red). Bars in (B,D) represent 10 µm. The edges of COS7 cells were visualized
by applying the Canny-Deriche filtering plugin of ImageJ (C) and the cell within
the square frame magnified (D) to visualize the plasma membrane region,
where NKCC2-IR is indicated with arrowheads. (E–G) Confocal images of
COS7 cells cultured in the presence of brefeldin-A (BFA 1 µg/ml 16 h, E) to
collapse Golgi membranes into the ER. NKCC2 was visualized using
Cy3-conjugated secondary antibodies (red). The edges of COS7 cells were
visualized as indicated in (C). The square in (F) indicates the cell magnified in
(G), where the plasma membrane location of NKCC2 is indicated with
arrowheads. Bars in (E,G) represent 10 µm.
expressed in COS7shNKCC1 (Figure 9F) but not in COS7shControl
(Figure 9E) is phosphorylated in S126 suggesting that the
transporter is functionally active. These results indicate that
FIGURE 7 | Sustained hyperosmotic stress promotes NKCC2A plasma
membrane localization independently of N-glycosylation.
Immunofluorescence microscopy images of COS7 cells transfected with
FLAG-tagged hNKCC2AWT (A), hNKCC2A1C (B), or hNKCC2AN446/456Q
(C) growing on glass coverslips in normotonic conditions (∼300 mOsm/kg
H2O) or in hyperosmotic (∼6.7%) media (320 mOsm/kg H2O) for 16 h. The
hyperosmotic media was prepared by adding 19.5mM mannitol to control
media (D–F). Cells were labeled by using FLAG antibodies coupled to
Cy3-conjugated secondary antibodies. Arrowheads in (D–F) represent
FLAG-NKCC2 expressed toward the edges of the cells. Bar represents 10µm
and applies to (E,D).
NKCC2A and NKCC1 are not redundant co-transporters when
co-expressed in the same cell and that plasmamembrane NKCC1
maintains cell size whereas NKCC2A does not.
DISCUSSION
The functional and pharmacological properties of NKCC2 have
been defined in amphibian heterologous expression systems such
as the Xenopus laevis oocyte (Gamba, 2005). Yet, relatively little
is known about NKCC2 function in mammalian cells models
that endogenously express this co-transporter, such as COS7
cells in culture. Further, the mechanisms involved in Slc12a1
gene expression and its regulation in mammalian cells are
not well understood. Previous work showed that COS7 cells
express NKCC2 (Alshahrani et al., 2015), a co-transporter that
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FIGURE 8 | COS7 in which NKCC1 was silenced were reduced in size. (A) Immunoblots of protein extracts obtained from COS7shNKCC1 cells at indicated
post-transfection cell passages. Immunoreactive bands were visualized using anti-NKCC1 and -NKCC2 antibodies coupled to HRP-conjugated secondary
antibodies. As controls of NKCC2 expression, protein extracts of COS7shControl and COS7shNKCC2 cells were immunoblotted against NKCC2. (B) Cell areas of
COS7shControl (mock transfected, filled bars) and COS7shNKCC1 cells (open bars). Cells at the indicated post-transfection passages (1–10) were plated on coverslips
and their cross sectional area (CSA) determined the day after, using ImageJ. Asterisks represent statistical significance respect to COS7shControl cells at the same
passage number (p < 0.05, n > 100 cells per group). (C) Direct fluorescence microscopy images of confluent COS7shControl (top), COS7shNKCC1 (center), and
COS7shNKCC2 cells (bottom) stably expressing GFP to visualize the reduced overall cell size of COS7shNKCC1 cells (p10). Bar represents 50µm. (D) Total and
BTD-sensitive components of Cl− uptake into COS7shControl and COS7shNKCC1 cells cultured under isotonic conditions in the absence of Cl− (light gray bars),
physiological concentrations of Cl− without (black bars) or with 10 µM BTD (dark gray bars). Results are expressed as nmol/µg protein ± SEM (n = 5). (E)
Fluorescence microscopy images of COS7shControl (top) and COS7shNKCC1 cells (bottom) where immunolabeled NKCC2 was detected using Dylight405-conjugated
secondary antibodies. Dashed circles denote the cell nuclei. Arrowheads indicate NKCC2 location toward the plasma membrane.
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FIGURE 9 | NKCC2A does not recover the decreased cell size of COS7shNKCC1 cells. (A–C) Direct fluorescence microscopy images of COS7shNKCC1 cells
(p10) grown in glass coverslips and stably expressing GFP from pGIPz-GFP.shNKCC1 constructs (A), transfected with mCherry-hNKCC2AWT (B) and superimposed
(C). (D) Mean CSA in COS7hNKCC1 cells transiently transfected with mock or mCherry-hNKCC2AWT (TFX). (E–F) Fluorescence microscopy images of COS7shControl
(E) and COS7shNKCC1 (F) where endogenous NKCC2 was immunolabeled by using antibodies against the activating phospho-residue pS126.
is generally thought to be expressed exclusively in the kidney’s
TALH. The present report confirms and extends these results by
showing that of the three main NKCC2 splice variants (A, B,
F) expressed in kidney, COS7 cells express NKCC2A, whereas
NKCC2B and NKCC2F are undetectable (Figures 1A–C). This
finding prompted us to study the trafficking and regulation of
NKCC2A using COS7 cells as a mammalian expression model
system.
The NKCC2 protein was found at low but significant levels in
COS7 cells when compared to kidney, where the co-transporter is
particularly abundant. For instance, to detect NKCC2 inWestern
blots, 100µg of protein extracts from COS7 cells were required,
instead of 10µg from kidney (Figure 1D). NKCC2 immunoblots
of protein extracts from COS7 cells exhibited a molecular mass
band pattern consistent with the transporter being expressed as
a protein with various degrees of N-glycosylation (Figure 1D).
However, most of NKCC2 from COS7 cells (densitometrically
estimated 80–90%) appeared as core/high mannose (∼120 kDa)
and hybrid-type N-glycans (∼135 kDa), whereas the complex N-
glycosylated version of the transporter (∼160 kDa) was barely
detected. These results are consistent with the relatively low
expression levels of the transporter in these cells and with
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the concept that complex N-glycosylation depends on the level
of cargo reaching the complex N-glycosylation machinery of
the Golgi, as has been suggested for many proteins (Stanley,
2011), including NKCC1 in COS7 cells (Singh et al., 2015) and
other ion transporters (Li et al., 2014). The low levels, or even
absence, of complex N-glycosylated NKCC2 is consistent with
the cellular distribution of the co-transporter in COS7 cells,
where most of the endogenous NKCC2 appeared localized in
intracellular compartments but not in the plasma membrane.
Consistent with the negligible plasma membrane expression is
the finding that integrin β2, a plasma membrane marker did not
co-localize with NKCC2 (Figures 2A–F), and the co-transporter
did not co-localize in lectin-labeled cells (Figures 2G–L). Further,
NKCC2 andNKCC1, a co-transporter that localizes to the plasma
membrane and in defined intracellular organelles (Maglova
et al., 2004; Singh et al., 2015) share some but not all cellular
compartments (Figures 2D–F). These results demonstrate that
endogenous NKCC2 in COS7 cells is mostly expressed in
intracellular compartments.
The above results are consistent with the localization of
NKCC2 in intracellular vesicles of the TALH in vivo (Nielsen
et al., 1998) and in rat medullary TALH cell lines in vitro
(Eng et al., 2007). In fact, only ∼3% of the total TALH
NKCC2 localized to the cell surface under basal conditions
(Ortiz, 2006). Moreover, endogenous NKCC2 has been found
in the perinuclear region of different cell types such as
insulin-secreting β-cells of the endocrine pancreas (Alshahrani
et al., 2012) and vasopressinergic/oxytocinergic neurons of the
hypothalamus (Konopacka et al., 2015). Interestingly, most of
the exogenously transfected NKCC2 localizes to the perinuclear
region of immortalized cell lines derived from mouse TALH
(mKTAL), opossum kidney (OKP) or HEK293 cells (Benziane
et al., 2007; Zaarour et al., 2009, 2011). Further, transfected
NKCC2 localizes to Rab11-positive vesicles and interacts with
secretory carrier-associated membrane protein 2 (Zaarour et al.,
2011), which is involved in post-Golgi recycling (van Ijzendoorn,
2006). In addition, it has been shown that NKCC2 interacts
with fructose-bisphosphate aldolase B (Benziane et al., 2007), a
glycolytic enzyme of demonstrated perinuclear/nuclear location
(Sáez and Slebe, 2000). Therefore, these data are consistent
with the notion that endogenous NKCC2A is predominantly
expressed in intracellular compartments.
In support of the above conclusion, NKCC2A was found
in Rab11-positive recycling endosomes (Figures 3A–C) and to
a lesser extent in cis/trans-Golgi cisternae (Figures 3D–I) and
the MTOC/centriolar compartment (Figures 3J–L). NKCC2 was
not found in lysosomes (Figures 3M–O) or tubulin-positive
filamentous structures radiating from theMTOC (Figures 3J–L),
a cellular pattern consistent with a protein that follows the
"classic" biosynthetic and secretory pathways. NKCC2 was also
found in the ER under basal conditions (Figures 4A–C), but
minimally after inhibition of global protein synthesis with CHX
(Figures 4D–F). However, in contrast with NKCC1 (Singh et al.,
2015), inhibition of the first step of N-glycosylation with TUN
did not result in retention or degradation of NKCC2 in ER-
like structures (Figure 5). In fact, TUN treatment surprisingly
redistributed endogenous NKCC2 to the plasma membrane
region of COS7 cells (Figures 6B–D). These findings suggest
that N-glycosylation of NKCC2A, either high-mannose, hybrid,
or complex, is not required for the transporter to reach the
plasma membrane. Even collapsing Golgi cisternae into the ER
of COS7 cells with BFA did not preclude NKCC2 transit to the
plasma membrane region (Figures 6E–G) demonstrating that
the transporter can reach that compartment independently of
the classic secretory pathway. These results are not a peculiarity
of NKCC2; similar observations have been reported for CFTR,
the cystic fibrosis conductance regulator (Yoo et al., 2002) and
other proteins that traffic directly from ER to plasma membrane
via endosomes, through routes independent of Golgi cisternae
(Grieve and Rabouille, 2011). Further, recruiting of NKCC2
to the plasma membrane has been recently shown in neurons
of the supraoptic and paraventricular nuclei in rats under
conditions in which the Golgi apparatus disintegrates (Iijima,
1970) such as chronic hyperosmotic stress (Konopacka et al.,
2015).
There are at least two non-mutually exclusive cellular
post-ER routes that may be taken by NKCC2 to reach the
plasma membrane: The “classic” secretory pathway and/or an
unconventional one that does not require Golgi cisternae.
Although the functional significance of such alternative pathways
is not clear, the election of one over the other appears
not related to the expression levels of NKCC2 or to the
ability of the transporter to become N-glycosylated. In fact,
hNKCC2A1C or hNKCC2AN446/456Q mutants that are normally
retained in intracellular compartments when over-expressed in
mammalian cells (Benziane et al., 2007; Zaarour et al., 2009)
or in COS7 (Figures 7A–C), did escape ER retention and
translocate to the plasma membrane region upon sustained
hyperosmotic stress (Figures 7D–F). Therefore, endogenous
natively expressed, core/high-mannose N-glycosylated and ER-
located NKCC2A may represent a pool of the transporter, which
may become available under certain physiological conditions
such as sustained hyperosmotic stress. In contrast to what
we have found for NKCC2A, ∼50% of non-glycosylatable rat
NKCC2F (rNKCC2FN442/452Q) reaches the plasma membrane
whereas the rNKCC2F activity is reduced by ∼80% when over-
expressed in X. Laevis oocytes (Paredes et al., 2006). Clearly,
these data indicate that∼50% of rNKCC2FN442/452Q still reaches
the plasma membrane and that rNKCC2FN442/452Q retains
∼20% of co-transport activity. It is possible that endogenous
NKCC2A, independently of its initial N-glycosylation state can
be targeted to the plasma membrane and/or retrieved from
recycling endosomes to the Golgi where it may be subjected
to complex N-glycosylation and trafficked back to the plasma
membrane, as a fully functional transporter. Taken together, the
present data suggest that NKCC2 trafficking and targeting can
bypass Golgi cisternae to reach the plasma membrane region of
COS7 cells subjected to sustained hyperosmotic stress. Notably,
NKCC2 expression and plasma membrane localization increase
in response to sustained pharmacologic inhibition of NKCC1
with BTD in COS7 and β-cells (Alshahrani et al., 2015) and
Konopacka et al. showed similar results in hypothalamic neurons
of rats under chronic hyperosmotic stress (Konopacka et al.,
2015).
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Our experiments suggest that COS7shNKCC1 cells are
significantly smaller than control cells (Figures 8A–C). This
observation needs to be taken within the following contexts:
(i) elimination of NKCC1 in COS7 cells took more than
10 passages (Figures 8A,B), which roughly corresponds to
∼8–9 weeks; (ii) once NKCC1 was fully silenced, NKCC2
increased to maximal levels of expression, and (iii) changes
in the cellular distribution of NKCC2 occurred in response to
sustained (>16 h) exposure to slight (∼6.7%) hyperosmotic
media. Therefore, the decreased cell size of COS7shNKCC1 cells
occurred regardless of NKCC2A up-regulation (Figure 8A),
suggesting that NKCC2A did not recover cell shrinkage resulting
from NKCC1 deficiency. This suggests that COS7shNKCC1
cells did not exhibit the typical regulatory volume increase
(RVI) widely described in the literature when animal cells are
exposed to extreme hyperosmotic solutions (50% hyperosmotic
or more). Thus, under the experimental conditions described
in the present study RVI was absent in cells lacking NKCC1
that up-regulate NKCC2, a co-transporter that does not
transport water. In line with the notion that NKCC2A may
not participate in cell water recovery is the observation that
insulin-secreting β-cells lacking NKCC1, but expressing low
levels of NKCC2, are significantly smaller when compared to
those expressing both NKCC1 and NKCC2 (Alshahrani and Di
Fulvio, 2012).
These results agree with data showing that, in addition
to translocating Na+, K+, and Cl− ions, NKCC1 does co-
transport water (Hamann et al., 2010) whereas NKCC2A does
not (Zeuthen and Macaulay, 2012). Therefore, up-regulation of
endogenous NKCC2 may restore intracellular concentration of
ions without restoring cell water volume in cells undergoing
slight but sustained shrinkage. In other words, our results suggest
that cells lacking NKCC1 exhibit reduced cellular water and ion
content per unit of mass. This hypothesis is supported by the
present results showing that COS7shNKCC1 cells are shrunken
(Figures 8B,C), and have reduced total Cl− content expressed
as nmol per µg of total cellular protein (Figure 8D) regardless
increased NKCC2 expression (Figure 8A) and plasmamembrane
localization (Figure 8E). However, the ratio cell area/total Cl−
content in COS7shNKCC1, relative to that of COS7shControl
cells, is similar. Further, over-expression of hNKCC2AWT in
COS7shNKCC1 failed to recover normal cell size (Figures 9A–C,
compare Figure 9D against Figure 8A) supporting the notion
that NKCC2A and NKCC1 are functionally different in terms
of water transport properties. It remains to be determined
weather in the absence of NKCC1, NKCC2 functions to keep
normal [Cl−]i and [K
+]i. In fact, COS7
shNKCC1 cells expressed
negligible BTD-sensitive Cl− uptake (Figure 8D) but they
still accumulate Cl−, suggesting that NKCC2A is resistant to
the action of BTD under the experimental conditions tested.
This is counterintuitive, given the fact that NKCC2 is the
target of the diuretic effect of BTD (Alvarez-Leefmans, 2012).
Interestingly, human NKCC2A and rNKCC2FN442/452Q are
3–4 and ∼2 times less sensitive, respectively, to BTD when
compared to their homologous NKCC2F variants (Paredes
et al., 2006; Carota et al., 2010). Although the BTD-sensitivity
profile of non-complex N-glycosylated NKCC2A expressed in
non-epithelial cells or in cells subjected to chronic dehydration
(Konopacka et al., 2015) or sustained osmotic stress remains
unknown, it is tempting to speculate that the apparent
refractoriness of NKCC2A to BTD may be required to secure
ion concentrations within normal ranges and within a context
of reduced cell size or water volume brought about sustained
hyperosmotic stress like the one observed in chronic systemic
dehydration.
Although the detailed molecular mechanisms whereby
cells lacking NKCC1 maintain their cell size reduced remain
unknown, NKCCs may have the potential to modulate cell size
independently of its ion transport capabilities. It is known that
NKCC1 (Garzon-Muvdi et al., 2012) and NKCC2 (Carmosino
et al., 2012) directly interact with ezrin/radixin/moesin (ERM)
proteins, which have been implicated in the regulation of the cell
shape, polarity, migration, and growth (Bretscher et al., 2002).
However, ERM proteins are activated acutely and transiently
in cells exposed to extreme, non-physiological-hyperosmotic
conditions e.g., 600 mOsm i.e., 100% hyperosmotic solutions
(Rasmussen et al., 2008). These conditions are in sharp
contrast with the modestly high (6 to 7%) hyperosmotic
solutions used in the present study, which fall within
physiological or physio-pathological ranges. Therefore, it
remains possible that an interaction NKCC2-ERM may regulate
cell size/shape when NKCC1 is silenced. In addition, cells
lacking NKCC1 require longer time to duplicate than WT
cells (roughly twice the time). It remains to be determined
whether this observation is directly related to reduced water
permeability in cells lacking NKCC1 but expressing increased
NKCC2. The high activation energy required for water
transport across COS7 cell membranes (Peckys et al., 2011)
is consistent with the idea that water not only permeates
via channels (aquaporins) but also through carrier-mediated
mechanisms, such as co-transporters. Therefore, it is also
plausible that NKCC1 elimination may decrease COS7 cells
water permeability.
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